Literature DB >> 31152939

Proteomic analysis reveals greater abundance of complement and inflammatory proteins in subcutaneous adipose tissue from postpartum cows treated with sodium salicylate.

C S Takiya1, S R Montgomery1, L K Mamedova1, G Kra2, N Nemes-Navon3, Y Levin4, S D Fleming5, B J Bradford1, M Zachut6.   

Abstract

This study aimed to investigate sodium salicylate (SS) treatment effects on the proteome of adipose tissue (AT) in postpartum cows. Twenty Holstein cows were assigned to control (CON, n = 10) or SS (n = 10) provided via drinking water (2.3 g/L) during the first 7 d of lactation. Subcutaneous AT was collected on d 7 of treatment and label-free quantitative shotgun proteomics and immunoblotting were analyzed in a subset of 5 AT per group. Eighty out of 1422 proteins (5.6%) were differentially abundant between CON and SS [fold change ±1.5, P < 0.05]. Top canonical pathways differing between CON and SS (Ingenuity) were complement system, interleukin-10 signaling, and acute phase response signaling. The abundances of complement C1r, C1qC, C1qB and C6 were greater in SS than CON. Regarding IL-10 signaling, the abundances of BLVRB, STAT3, and lipopolysaccharide binding protein (LBP) were greater in SS AT compared to CON. Immunoblots revealed increased abundance of paraoxanase-1 and tumor necrosis factor-alpha, as well as a tendency for greater abundance of cluster differentiation 172a in SS AT, which may indicate of increased macrophage infiltration. SS treatment postpartum likely promotes inflammatory signaling in AT of dairy cows, perhaps due to immune cell recruitment. SIGNIFICANCE: This work demonstrates that treating early lactating cows with sodium salicylate, an anti-inflammatory agent that has been shown to have metabolic effects and increase milk production in dairy cows, affects the proteome of subcutaneous adipose tissue in early lactating dairy cows. Unexpectedly, sodium salicylate treatment enriched inflammatory pathways of the complement system, cytokine signaling, and acute phase response, as revealed by proteomic analysis of subcutaneous adipose tissues from cows at 7 d postpartum. These findings imply that SS treatment during the first 7 d of lactation likely promotes inflammatory signaling in AT of the dairy cow, perhaps due to immune cell recruitment. Tissue-specific impacts of systemic sodium salicylate requires further scrutiny.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adipose tissue; Inflammation; Non-steroidal anti-inflammatory drug; Proteomics; Transition period

Year:  2019        PMID: 31152939     DOI: 10.1016/j.jprot.2019.103399

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  4 in total

1.  Proteomic analysis of adipose tissue revealing differentially abundant proteins in highly efficient mid-lactating dairy cows.

Authors:  Yehoshav A Ben Meir; Jayasimha R Daddam; Gitit Kra; Hadar Kamer; Yuri Portnick; Yishai Levin; Maya Zachut
Journal:  Sci Rep       Date:  2022-06-13       Impact factor: 4.996

2.  iTRAQ-Based Quantitative Proteomic Comparison of 2D and 3D Adipocyte Cell Models Co-cultured with Macrophages Using Online 2D-nanoLC-ESI-MS/MS.

Authors:  Sun Young Lee; Sung Bum Park; Young Eun Kim; Hee Min Yoo; Jongki Hong; Kyoung-Jin Choi; Ki Young Kim; Dukjin Kang
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

3.  Transcriptomic profiling of adipose tissue inflammation, remodeling, and lipid metabolism in periparturient dairy cows (Bos taurus).

Authors:  David Salcedo-Tacuma; Jair Parales-Giron; Crystal Prom; Miguel Chirivi; Juliana Laguna; Adam L Lock; G Andres Contreras
Journal:  BMC Genomics       Date:  2020-11-23       Impact factor: 3.969

4.  Proteome dataset of subcutaneous adipose tissue from postpartum cows treated with sodium salicylate.

Authors:  Caio Takiya; Shawnee Montgomery; Laman Mamedova; Gitit Kra; Nataly Nemes-Navon; Yishai Levin; Sherry Fleming; Barry Bradford; Maya Zachut
Journal:  Data Brief       Date:  2019-09-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.